MENU
RDY
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Dr. Reddy's Laboratories (RDY) Ownership - Who owns Dr. Reddy's Laboratories?

Dr... Show more

Profile

Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
11.37B
P/E Ratio
17.42
Total Cash
69.81B
Projected Growth
3.37
Total Debt
58.54B
Revenue
342.15B
Risk (Beta)
0.53
Dividend Yield
0.01
Total Cash/Share
83.85
Total Debt/Equity
49.28
Revenue/Share
4.58 USD as % of share price

Fundamentals

RDY
Capitalization
11.4B
P/E Ratio
17.42
Risk (Beta)
0.53
Dividend Yield
0.01
Total Cash
69.8B
Total Cash/Share
83.85
Total Debt
58.5B
Total Debt/Equity
49.28
Projected Growth (PEG Ratio)
3.37
Revenue/Share (as % of the share price)
4.58%
Revenue
342B
ROE
N/A
Book Value
358B
P/B Ratio
2.84
Cash Flow
N/A
Earnings
70.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
835M
Current Ratio
1.85
Current Revenue Per Employee
3166049.50
Dividends Per Share - Security
8.02
EBITDA
98.5B
Float
N/A
Float - Current
N/A
Gross Income Margin
54.67
Revenue To Assets
10.82
Shares Held By Institutions
2.64B
Shares Outstanding - Current
833M
Total Liabilities
180B
Total Volume MTD
N/A
Value
-1
Gain YTD
-12.948
View a ticker or compare two or three
RDY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RDY showed earnings on October 24, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com